Australia markets closed

Vir Biotechnology, Inc. (VIR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
9.56+0.02 (+0.16%)
As of 09:50AM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
43,986
39,494
1,580,472
1,087,068
67,245
Cost of revenue
917
2,765
146,319
65,865
0
Gross profit
43,069
36,729
1,434,153
1,021,203
67,245
Operating expenses
Research development
532,153
589,671
474,648
448,006
302,411
Selling general and administrative
167,544
178,049
161,762
160,793
70,937
Total operating expenses
664,084
721,034
601,085
600,452
364,225
Operating income or loss
-621,015
-684,305
833,068
420,751
-296,980
Total other income/expenses net
-15,957
-30,879
-106,880
128,612
-4,467
Income before tax
-550,006
-628,194
754,280
549,802
-298,611
Income tax expense
-10,569
-13,077
238,443
21,218
54
Income from continuing operations
-539,437
-615,117
515,837
528,584
-298,665
Net income
-539,437
-615,061
515,837
528,584
-298,665
Net income available to common shareholders
-539,437
-615,061
515,837
528,584
-298,665
Basic EPS
-4.50
-4.59
3.89
4.07
-2.51
Diluted EPS
-4.50
-4.59
3.83
3.96
-2.51
Basic average shares
133,768
134,131
132,607
129,885
119,159
Diluted average shares
134,254
134,131
134,811
133,437
119,159